Hydroxychloroquine (HC)

DRUG2 trials

Sponsors

University of Pittsburgh, Sun Yat-sen University

Conditions

Melanoma MetastaticNRAS MutationRenal Cell Carcinoma

Phase 1

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

TerminatedNCT01144169

University of PittsburghRenal Cell Carcinoma

Start: 2010-10-31End: 2016-09-30Updated: 2016-10-26

Phase 2

Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma

RecruitingNCT07750067

Sun Yat-sen UniversityMelanoma Metastatic, NRAS Mutation

Start: 2026-04-01End: 2030-07-28Target: 37Updated: 2026-08-10